News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
814,616 Results
Type
Article (74350)
Company Profile (644)
Press Release (739622)
Section
Business (227450)
Career Advice (3720)
Deals (39308)
Drug Delivery (128)
Drug Development (89338)
Employer Resources (198)
FDA (17839)
Job Trends (17122)
News (387718)
Policy (38749)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (12)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (7)
2025 BioForest Digital (6)
2025 Lone Star Bio Digital (10)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2991)
Academic (1)
Accelerated approval (5)
Adcomms (29)
Allergies (88)
Alliances (55938)
ALS (93)
Alzheimer's disease (1478)
Antibody-drug conjugate (ADC) (141)
Approvals (17805)
Artificial intelligence (277)
Autoimmune disease (22)
Automation (14)
Bankruptcy (402)
Best Places to Work (12633)
BIOSECURE Act (21)
Biosimilars (115)
Biotechnology (440)
Bladder cancer (65)
Brain cancer (30)
Breast cancer (272)
Cancer (2170)
Cardiovascular disease (189)
Career advice (3166)
Career pathing (33)
CAR-T (161)
Cell therapy (451)
Cervical cancer (21)
Clinical research (71946)
Collaboration (841)
Compensation (479)
Complete response letters (30)
COVID-19 (2858)
CRISPR (43)
C-suite (232)
Cystic fibrosis (105)
Data (2029)
Decentralized trials (2)
Denatured (41)
Depression (50)
Diabetes (275)
Diagnostics (6882)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (123)
Drug pricing (122)
Drug shortages (33)
Duchenne muscular dystrophy (93)
Earnings (93459)
Editorial (39)
Employer branding (25)
Employer resources (167)
Events (128134)
Executive appointments (692)
FDA (19024)
Featured Employer (64)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (746)
Gene editing (110)
Generative AI (27)
Gene therapy (325)
GLP-1 (823)
Government (5068)
Grass and pollen (5)
Guidances (49)
Healthcare (20862)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (129)
Indications (27)
Infectious disease (3007)
Inflammatory bowel disease (148)
Inflation Reduction Act (11)
Influenza (53)
Intellectual property (91)
Interviews (727)
IPO (17723)
IRA (51)
Job creations (4989)
Job search strategy (2594)
Kidney cancer (10)
Labor market (38)
Layoffs (539)
Leadership (20)
Legal (9905)
Liver cancer (76)
Lung cancer (317)
Lymphoma (139)
Machine learning (4)
Management (65)
Manufacturing (304)
MASH (68)
Medical device (14565)
Medtech (14570)
Mergers & acquisitions (22061)
Metabolic disorders (730)
Multiple sclerosis (79)
NASH (23)
Neurodegenerative disease (103)
Neuropsychiatric disorders (31)
Neuroscience (2022)
NextGen: Class of 2025 (7635)
Non-profit (5075)
Northern California (2509)
Now hiring (38)
Obesity (397)
Opinion (270)
Ovarian cancer (75)
Pain (89)
Pancreatic cancer (79)
Parkinson's disease (147)
Partnered (21)
Patents (221)
Patient recruitment (100)
Peanut (51)
People (63869)
Pharmaceutical (133)
Pharmacy benefit managers (21)
Phase I (22232)
Phase II (31375)
Phase III (23669)
Pipeline (1103)
Podcasts (119)
Policy (140)
Postmarket research (3258)
Preclinical (9762)
Press Release (72)
Prostate cancer (99)
Psychedelics (38)
Radiopharmaceuticals (267)
Rare diseases (405)
Real estate (7148)
Recruiting (75)
Regulatory (25943)
Reports (57)
Research institute (2653)
Resumes & cover letters (579)
Rett syndrome (4)
RNA editing (4)
RSV (47)
Schizophrenia (76)
Series A (133)
Series B (84)
Service/supplier (26)
Sickle cell disease (57)
Southern California (2187)
Special edition (18)
Spinal muscular atrophy (165)
Sponsored (33)
Startups (4194)
State (2)
Stomach cancer (16)
Supply chain (67)
Tariffs (14)
The Weekly (76)
United States (22759)
Vaccines (774)
Venture capitalists (39)
Webinars (13)
Weight loss (291)
Women's health (37)
Worklife (19)
Date
Today (119)
Last 7 days (772)
Last 30 days (2866)
Last 365 days (36086)
2025 (8875)
2024 (37898)
2023 (42567)
2022 (53926)
2021 (58723)
2020 (57663)
2019 (51302)
2018 (39084)
2017 (36837)
2016 (37746)
2015 (43738)
2014 (38423)
2013 (34408)
2012 (36309)
2011 (36431)
2010 (35861)
Location
Africa (1192)
Alabama (56)
Alaska (7)
Arizona (240)
Arkansas (14)
Asia (48660)
Australia (8348)
California (5846)
Canada (1918)
China (510)
Colorado (264)
Connecticut (281)
Delaware (137)
Europe (109504)
Florida (853)
Georgia (209)
Hawaii (1)
Idaho (63)
Illinois (575)
India (28)
Indiana (315)
Iowa (10)
Japan (146)
Kansas (106)
Kentucky (27)
Louisiana (12)
Maine (69)
Maryland (906)
Massachusetts (4539)
Michigan (234)
Minnesota (398)
Mississippi (2)
Missouri (87)
Montana (31)
Nebraska (26)
Nevada (58)
New Hampshire (68)
New Jersey (1676)
New Mexico (31)
New York (1671)
North Carolina (1071)
North Dakota (8)
Northern California (2509)
Ohio (207)
Oklahoma (15)
Oregon (45)
Pennsylvania (1301)
Puerto Rico (10)
Rhode Island (30)
South America (1564)
South Carolina (19)
South Dakota (1)
Southern California (2187)
Tennessee (97)
Texas (881)
Utah (175)
Virginia (152)
Washington D.C. (65)
Washington State (560)
West Virginia (3)
Wisconsin (61)
814,616 Results for "chugai pharmaceutical co ltd japan".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Araris Biotech AG Announces Research Collaboration and Option to License Agreement with Chugai Pharmaceutical Co. to Develop Next-Generation ADCs Using Araris’ AraLinQ™ technology
January 8, 2025
·
2 min read
Press Releases
Newron and EA Pharma (A Subsidiary of Eisai Co., Ltd.) Announce License Agreement for Evenamide in Japan and Other Asian Territories
December 13, 2024
·
11 min read
Press Releases
Inari Medical Announces Reimbursement Approval for ClotTriever® Thrombectomy System in Japan and New Distribution Partnership with Medikit Co., Ltd.
December 3, 2024
·
4 min read
Press Releases
Alumis and Kaken Pharmaceutical Announce Collaboration and Licensing Agreement for ESK-001 in Dermatology in Japan
March 25, 2025
·
7 min read
Press Releases
WORK Medical Technology Group LTD Announces Strategic Partnership with Shanghai Chartwell Medical Device Co., Ltd.
March 3, 2025
·
5 min read
Mergers & acquisitions
Taiho Pharmaceutical Buys ADC Partner Araris for up to $1.1B Total
Japan-based Taiho Pharmaceutical has worked with Araris Biotech since 2023 developing antibody-drug conjugates for the oncology space.
March 17, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Merck Enters Exclusive License Agreement for HRS-5346, an Investigational Oral Lipoprotein(a) Inhibitor, for Cardiovascular Disease from Jiangsu Hengrui Pharmaceuticals Co., Ltd.
March 25, 2025
·
5 min read
Drug Development
Verrica Pharmaceuticals’ Development and Commercialization Partner, Torii Pharmaceutical Co., Ltd., Announces Positive Top-line Results from a Confirmatory Phase 3 Trial of TO-208 for the Treatment of Molluscum Contagiosum in Japan
Verrica Pharmaceuticals Inc. announced that its development and commercialization partner, Torii Pharmaceutical Co., Ltd., reported positive top-line results from its Phase 3 trial of TO-208 for the treatment of Molluscum Contagiosum in Japan.
December 15, 2023
·
4 min read
Press Releases
GE HealthCare Completes Acquisition of Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan
March 31, 2025
·
4 min read
Business
Verrica Pharmaceuticals Announces Amendment to Company’s Collaboration and License Agreement with Torii Pharmaceutical Co. Ltd. to Fund Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Common Warts
Verrica Pharmaceuticals Inc. today announced that it has entered into an amendment to its existing licensing agreement with Torii Pharmaceutical Co. Ltd. (Torii), to jointly conduct a global pivotal Phase 3 clinical trial of YCANTH® for the treatment of common warts.
May 15, 2024
·
9 min read
1 of 81,462
Next
